A. L. Chighizola-cb, . Banzato-a, R. Pons-estel-gj, J. G. De, and . Erkan-d, Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis : a critical rewiew of the literature, Arthritis Care Res, issue.11, pp.65-1869, 2013.

B. G. Les-molécules-de-la-vie, Site disponible sur : http://www.cegep-stefoy .qc.ca/profs, p.6, 2015.

C. , P. J. Guettrot-imbert, . Le-guern-v, . Leroux-g, . Marra-d et al., Adherence to treatment in systemic lupus erythematosus patients, Best Practice & Research Clinical Rheumatology, p.27, 2013.

G. C. Wahl-d, Le syndrome des antiphospholipides en néphrologie Atteinte rénale et aspects pratiques de la prise en charge, pp.1-9, 2014.

H. Ld, D. J. Young, and . Hughes, A 5 item version of the Compliance Questionnaire for Rheumatology (CQR5) successfully identifies low adherence to DMARDs, BMC Musculoskeletal Disorders, vol.14, p.286, 2013.

K. Gillaizeau-f, P. J. Lenain-e, . N. Postel-vinay, . Plouin-p.-f, . Durieux-p et al., Validation of a french version of the 8-item Morisky Medication Adherence Scale in hypertensive adults, The Journal of Clinical Hypertension, issue.7, pp.14-429, 2012.

L. Moniteur, D. Pharmacies-(-coordonné-par, and B. F. , Spécial AVK 2 ème partie, les entretiens de suivi, pp.2972-2976

L. Moniteur, D. Pharmacies-(-coordonné-par, and B. F. , Spécial AVK et nouveaux anticoagulants oraux 1 ère partie, pp.2966-2970

M. S. Lockshin-md, A. T. Branch-dw, C. R. Brey-rl, . Derksen-rh, . De-groot-pg et al., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, vol.4, issue.2, pp.295-306, 2006.

M. S. Lockshin-m and . T. Atsumi, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, issue.4, pp.295-306, 2006.

P. C. , C. Z. , P. M. Gross-r, M. J. , C. J. et al., Adherence to Warfarin assessed by electronic pill caps, clinician assessment, and patient reports : results from IN-RANGE study, Society of General Internal Medicine, pp.22-1254, 2007.

P. A. , R. A. Localio, C. M. Brensinger-c, C. J. Gross-r, P. C. et al., Can we predict daily adherence to warfarin ? Results from the inernational normalized ratio Adherence and genetics (IN-RANGE) Study, CHEST, vol.137, issue.4, pp.883-889, 2010.

S. J. and A. A. Fischer-a.-m, Hydroxychloroquine: une nouvelle approche thérapeutique des manifestations thrombotiques du syndrome des antiphospholipides. La revue de médecine interne, pp.31-854, 2010.

V. D. Durand and . Le, Dorosz, guide pratique des médicaments, 32 ème édition, 1905.

W. Phospholipid, Site disponible sur: http://en.wikipedia.org/wiki/Phospholipid, p.6, 2015.

Z. S. De-laat-b, M. S. , K. H. Shums-z, A. R. Norman-gl, . C. Lamboux-matthieu et al., TAC(I)T INVESTIGATORS. Validity of the global anti-phospholipid syndrome score to predict thrombosis : a prospective multicentre cohort study, Rheumatology, p.2015